3.0400
-0.0400
(-1.30%)
As of 8:08:40 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in GBP | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 11 | 12 |
| Avg. Estimate | 4.78B | 4.86B | 19.05B | 20.38B |
| Low Estimate | 4.78B | 4.86B | 18.04B | 18.91B |
| High Estimate | 4.78B | 4.86B | 19.75B | 21.9B |
| Year Ago Sales | 4.52B | 4.55B | 18.44B | 19.05B |
| Sales Growth (year/est) | 5.64% | 6.93% | 3.27% | 7.01% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LLD2.F | -- | -- | -- | -- |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
| Downgrade | Keefe, Bruyette & Woods: Outperform to Market Perform | 3/11/2025 |
| Downgrade | Citigroup: Buy to Neutral | 8/5/2024 |
| Downgrade | UBS: Buy to Neutral | 7/30/2024 |
| Initiated | Berenberg: Hold | 4/25/2024 |
| Upgrade | B of A Securities: Neutral to Buy | 3/21/2024 |
| Downgrade | Morgan Stanley: Overweight to Equal-Weight | 10/17/2022 |